Dixon Hughes Goodman Wealth Advisors’s Amedisys AMED Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$5K	Buy	+30	New	+$4.48K	﹤0.01%	586

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's AMED Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in Amedisys (AMED) in Q1 2022: 30 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #586 among its holdings.

328 funds tracked by Wall St. Rank hold AMED as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 30 shares of Amedisys worth $5K as of Q1 2022.
Amedisys was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
Amedisys made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #586 holding.
328 funds tracked by Wall St. Rank held Amedisys as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.